Products & ReviewLife Sciences

CYFRA 21-1 CLIA

DRG International Inc.CLA-4731Available: Worldwide

High Quality Assays with Reproducible and Reliable Results

DRG International Inc.

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Write your own review

A chemiluminescence immunoassay for the quantitative measurement of CYFRA 21-1 in serum and heparin plasma.CYFRA 21-1 is a fragment of cytokeratin 19. Although expressed in all body tissues its major occurrence is in the lung, particulary in lung cancer tissues. The major diagnostic importance of CYFRA 21-1 as a tumor marker is in differential diagnosis, prognosis, and aftercare of non-small-cell lung cancer (NSCLC) patients. Additionally, CYFRA 21-1 has been described as a tumor marker for the monitoring of bladder cancer. The DRG CYFRA 21-1 CLIA uses the two mouse monoclonal antibodies KS19.1 and BM19.21 to determine cytokeratin 19 fragments.The DRG CYFRA 21-1 CLIA is a chemiluminescence immunoassay (CLIA), based on the sandwich principle. The microtiter wells are coated with a monoclonal [mouse] antibody directed towards a unique antigenic site on the CYFRA 21-1 molecule. An aliquot of sample containing endogenous CYFRA 21-1 is incubated in the coated well with enzyme conjugate, which is an anti CYFRA 21-1 antibody conjugated with horseradish peroxidase. After incubation the unbound conjugate is washed off. The amount of bound peroxidase is proportional to the concentration of CYFRA 21-1 in the sample. After addition of the substrate solution, the intensity of emitted light is proportional to the concentration of CYFRA 21-1 in the sample.

Product Overview

Links